Audax Private Equity Announces the Acquisition of Altasciences Clinical Research

BOSTON–(BUSINESS WIRE)– Audax Private Equity (“Audax”) announced that it has partnered with
management to acquire Altasciences Company, Inc. (“Altasciences”), a
leading early phase contract research organization (CRO) in North
America. Audax acquired Altasciences from Kilmer Capital Partners, a
private equity firm based in Toronto, Canada. Terms of the transaction
were not disclosed.

Altasciences, headquartered in Laval, Quebec, encompasses Algorithme
Pharma, Vince & Associates Clinical Research, and Algorithme Pharma USA.
Altasciences offers expertise in the execution of a wide range of New
Drug Application (NDA) enabling clinical trials and support services
including data management, biostatistics, medical writing, and
bioanalysis.

Geoffrey S. Rehnert, Co-Chief Executive Officer, Audax
Group, said, “Altasciences is a leader in the early phase
clinical research industry. We look forward to working with Chris Perkin
and the Altasciences team to continue building a leading platform
through organic growth and add-on acquisitions.”

Chris Perkin, Chief Executive Officer, Altasciences, said
“We are excited to be partnering with Audax for the next stage of our
growth. Audax brings expertise and resources that will help us continue
to build our market leadership position by expanding our service
offering and value proposition to our clients through strategic
acquisitions and growth initiatives.”

Fairmount Partners served as financial advisor to Altasciences. Blake,
Cassels & Graydon, LLP and Kirkland & Ellis, LLP served as counsel to
Audax.

ABOUT AUDAX PRIVATE EQUITY
Since its founding in 1999, Audax
Private Equity has been focused on building leading middle market
companies. Audax has invested $4 billion in 105 platform and 573 add-on
companies. Through its disciplined Buy & Build approach, Audax seeks to
help platform companies execute add-on acquisitions that fuel revenue
growth, optimize operations, and significantly increase equity value.
Audax Private Equity is an integral part of Audax Group, an alternative
asset management firm specializing in investments in middle market
companies. With offices in Boston, New York, and San Francisco, Audax
Group has over $11 billion in assets under management across its Private
Equity, Mezzanine, and Senior Debt businesses. For more information,
visit the Audax Group website, www.audaxgroup.com.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170613005980/en/